Core Viewpoint - The recommendation to buy the AdvisorShares Pure US Cannabis ETF (MSOS) is reiterated, indicating a positive outlook on the cannabis sector [1]. Group 1: Investment Thesis - The article serves as a continuation of the initial coverage thesis published on December 17, 2025, which also had a Buy recommendation [1]. - The analysis is backed by over 7 years of experience in equity analysis in Latin America, providing clients with in-depth research and insights [1].

Core Insights - Amplify Seymour Cannabis ETF (NYSEARCA:CNBS) achieved a 17% gain in 2025, indicating a positive performance in the cannabis sector [1] Group 1 - The 17% gain in 2025 may not fully reflect the underlying challenges faced by the cannabis industry [1] - The ETF's performance is influenced by various market dynamics and regulatory changes affecting cannabis companies [1] - Investors should consider the broader context of the cannabis market when evaluating the ETF's performance [1]

Core Viewpoint - UC Asset Limited Partnership (UCASU) supports President Trump's decision to reschedule marijuana from Schedule I to Schedule III, marking a significant deregulation for the cannabis industry [1] Group 1: Company Overview - UC Asset is one of only four US public companies focused on investing in cannabis properties, claiming to have the "best performing" cannabis property portfolio among its peers [2] - The company has nearly doubled its cannabis property portfolio from $1.6 million to $3.1 million earlier this year [3] Group 2: Investment Strategy - UC Asset has developed an investment plan anticipating a policy breakthrough in the cannabis industry, which has guided its recent acquisitions [3] - The company has filed for a $5 million Secondary Public Offering (SPO) to acquire two additional cannabis properties, with plans to launch fundraising in March 2026 [4] - In addition to the SPO, UC Asset is selling about $3 million of its legacy assets and exploring other financing options, aiming to expand its cannabis portfolio by 400% to approximately $12 million in 2026 [5] Group 3: Performance Metrics - UC Asset reports a 14.4% Return on Investment (ROI) for its cannabis portfolio, significantly above the industry average and outperforming similar portfolios held by other public companies [6] - The company projects its cannabis portfolio will maintain an ROI between 13.5% and 14.5% for 2025, with potential increases above 15% in 2026 [7]

Core Viewpoint - The Amplify Seymour Cannabis ETF (CNBS) has experienced significant growth, reaching a 52-week high and increasing by 199.07% from its 52-week low price of $13.96/share, indicating strong momentum in the cannabis sector [1][2]. Group 1: Fund Performance - CNBS employs an active strategy to provide diversified exposure across the U.S. cannabis ecosystem, charging 76 basis points in annual fees [1]. - The fund has a positive weighted alpha of 19.45, suggesting potential for further gains in the near term [3]. Group 2: Market Drivers - The cannabis sector is gaining renewed attention due to President Trump's plan to ease federal regulations on marijuana, which could serve as a significant policy tailwind [2]. - Reclassifying marijuana to a lower-risk category could enhance research funding and improve access to capital by reducing legal constraints [2].

Group 1 - The Hecht Commodity Report is a comprehensive source for commodities analysis, covering market movements of over 29 different commodities and providing various trading recommendations [1][2] - The AdvisorShares Pure Cannabis ETF (YOLO) is highlighted as one of the most liquid cannabis ETFs, trading at $2.93 per share with nearly $38 million in assets under management as of December 2 [2] Group 2 - The report includes bullish, bearish, and neutral calls, along with actionable ideas for traders and investors [1][2]

Group 1 - The Hecht Commodity Report is a comprehensive resource for commodities, forex, and precious metals, covering market movements of over 29 different commodities [1] - The report provides bullish, bearish, and neutral calls along with directional trading recommendations and actionable ideas for traders and investors [1][2] - AdvisorShares Pure Cannabis ETF (YOLO) is highlighted as a liquid cannabis ETF, trading at $2.93 per share with nearly $38 million in assets under management as of December 2 [2] Group 2 - YOLO trades an average of over 36,000 shares, indicating significant trading activity [2] - The author, Andrew Hecht, has extensive experience on Wall Street, specifically in commodities and precious metals, and runs The Hecht Commodity Report [2]

Core Viewpoint - Cannabis stocks have experienced significant growth recently, driven by favorable developments in Washington, including President Trump's endorsement of CBD for seniors and discussions about reclassifying marijuana as a schedule 3 drug [1][4]. Industry Overview - Cannabis stocks have doubled in value over the past three months amid hopes for federal reform, although past experiences have made investors cautious about the sustainability of this growth [2][6]. - The cannabis industry has faced challenges over the last five years, particularly due to unfulfilled promises of reform from politicians [3][6]. Regulatory Environment - Currently classified as a schedule one drug, there are discussions about rescheduling cannabis to schedule three, which would involve coordination between the Department of Health and Human Services (HHS) and the Drug Enforcement Administration (DEA) [4][5]. - An executive order from President Trump could initiate this rescheduling process, but congressional support and involvement from the Department of Justice (DOJ) would still be necessary [5]. Investment Landscape - There is a notable disconnect in the U.S. cannabis investment landscape, where Canadian companies can list on major U.S. exchanges despite restrictions on THC cannabis operations in the U.S. [7][8]. - U.S. multi-state operators, which conduct significant business in states with medical cannabis dispensaries, face challenges due to federal law, including limitations on banking and exchange listings [9][10]. Market Dynamics - The largest cannabis fund in the world focuses on U.S. multi-state operators and is listed on the New York Stock Exchange, providing investors with access to these companies [10]. - Rescheduling cannabis could trigger a domino effect, allowing these companies to access banking services and institutional investments, potentially reversing losses from the past five years [11]. Company Highlights - Top investment picks include Cural Leaf, True Leave, Cresco Labs, and Verono, which are positioned well for potential reform and operate in multiple states [12][13].